# Biofrontera Inc.: filings

BFRI · Nasdaq · CIK 1858685 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bfri.md) · [Financials](/companies/bfri/financials.md) · [Filings](/companies/bfri/filings.md) · [Insiders](/companies/bfri/insiders.md)

## Reports and events: 164 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 99, 4 40, CORRESP 28, 3 19, S-1/A 16, UPLOAD 16, 10-Q 15, EFFECT 11, S-1 11, SC 13G 10, SCHEDULE 13G/A 9, 424B3 8, DEF 14A 8, D 7, SC 13G/A 7, 4/A 6, 10-K 5, 8-K/A 4, DRS 4, DRSLTR 4, PRE 14A 4, DEFA14A 3, DEFR14A 3, S-8 3, SCHEDULE 13D/A 3, 424B4 2, 8-A12B 2, 8-A12B/A 2, DRS/A 2, FWP 2, POS EX 2, SEC STAFF LETTER 2, 10-K/A 1, 25-NSE 1, CERT 1, NT 10-K 1, POS AM 1, RW 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 09:29 ET | [8-K](/filings/0001493152-26-042508.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042508 |
| 2026-08-13 | 16:41 ET | [10-Q](/filings/0001493152-26-037834.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037834 |
| 2026-08-13 | 09:00 ET | [8-K](/filings/0001493152-26-037610.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037610 |
| 2026-07-22 | 16:40 ET | [10-K/A](/filings/0001493152-26-034251.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-034251 |
| 2026-06-17 | 16:05 ET | [8-K](/filings/0001493152-26-029079.md) | 5.07 Shareholder vote results | 0001493152-26-029079 |
| 2026-05-14 | 16:28 ET | [10-Q](/filings/0001493152-26-023119.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023119 |
| 2026-05-14 | 08:00 ET | [8-K](/filings/0001493152-26-022875.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022875 |
| 2026-04-30 | 16:40 ET | [DEF 14A](/filings/0001493152-26-020616.md) | Proxy statement, period 2026-04-30 | 0001493152-26-020616 |
| 2026-03-19 | 16:15 ET | [10-K](/filings/0001493152-26-011625.md) | Annual report, period 2025-12-31 | 0001493152-26-011625 |
| 2026-03-19 | 09:35 ET | [8-K](/filings/0001493152-26-011545.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-011545 |
| 2026-03-09 | 09:20 ET | [8-K](/filings/0001493152-26-009321.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009321 |
| 2026-02-26 | 09:20 ET | [8-K](/filings/0001493152-26-008136.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-008136 |
| 2026-02-09 | 09:20 ET | [8-K](/filings/0001493152-26-005717.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005717 |
| 2026-01-13 | 08:35 ET | [8-K](/filings/0001493152-26-001959.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-001959 |
| 2026-01-07 | 16:30 ET | [8-K](/filings/0001493152-26-000823.md) | 3.01 Delisting notice | 0001493152-26-000823 |
| 2025-12-05 | 17:15 ET | [S-1](/filings/0001493152-25-026443.md) | Registration statement | 0001493152-25-026443 |
| 2025-11-13 | 08:30 ET | [8-K](/filings/0001493152-25-022133.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022133 |
| 2025-11-12 | 16:31 ET | [10-Q](/filings/0001493152-25-021945.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021945 |
| 2025-11-10 | 16:30 ET | [8-K](/filings/0001493152-25-021525.md) | 8.01 Other events | 0001493152-25-021525 |
| 2025-11-07 | 08:05 ET | [8-K](/filings/0001493152-25-021189.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021189 |
| 2025-10-24 | 17:29 ET | [8-K](/filings/0001493152-25-019370.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019370 |
| 2025-10-23 | 08:50 ET | [8-K](/filings/0001493152-25-019006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-019006 |
| 2025-09-19 | 16:45 ET | [8-K](/filings/0001493152-25-014281.md) | 5.07 Shareholder vote results | 0001493152-25-014281 |
| 2025-09-19 | 15:04 ET | [SCHEDULE 13D/A](/filings/0001213900-25-089466.md) | Ownership report, active investor, amended | 0001213900-25-089466 |
| 2025-08-13 | 17:30 ET | [S-1/A](/filings/0001641172-25-023615.md) | Registration statement, amended | 0001641172-25-023615 |
| 2025-08-13 | 17:22 ET | [8-K](/filings/0001641172-25-023598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023598 |
| 2025-08-13 | 16:16 ET | [10-Q](/filings/0001641172-25-023486.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023486 |
| 2025-08-11 | 17:10 ET | [8-K](/filings/0001641172-25-023006.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023006 |
| 2025-08-05 | 16:15 ET | [DEF 14A](/filings/0001641172-25-022261.md) | Proxy statement, period 2025-08-05 | 0001641172-25-022261 |
| 2025-07-25 | 14:31 ET | [SCHEDULE 13D/A](/filings/0001213900-25-067663.md) | Ownership report, active investor, amended | 0001213900-25-067663 |
| 2025-07-16 | 17:28 ET | [S-1](/filings/0001641172-25-019928.md) | Registration statement | 0001641172-25-019928 |
| 2025-07-16 | 16:05 ET | [8-K/A](/filings/0001641172-25-019884.md) | 9.01 Financial statements and exhibits | 0001641172-25-019884 |
| 2025-07-01 | 08:55 ET | [8-K](/filings/0001641172-25-017285.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-017285 |
| 2025-06-30 | 08:05 ET | [8-K](/filings/0001641172-25-017052.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017052 |
| 2025-06-18 | 16:15 ET | [8-K](/filings/0001641172-25-015584.md) | 5.07 Shareholder vote results | 0001641172-25-015584 |
| 2025-06-11 | 15:00 ET | [8-K](/filings/0001641172-25-014674.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014674 |
| 2025-06-03 | 17:15 ET | [8-K](/filings/0001641172-25-013491.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-013491 |
| 2025-05-23 | 16:30 ET | [8-K](/filings/0001641172-25-012285.md) | 3.01 Delisting notice | 0001641172-25-012285 |
| 2025-05-15 | 17:10 ET | [8-K](/filings/0001641172-25-011069.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-011069 |
| 2025-05-15 | 16:45 ET | [10-Q](/filings/0001641172-25-011031.md) | Quarterly report, period 2025-03-31 | 0001641172-25-011031 |
| 2025-05-14 | 16:52 ET | [8-K](/filings/0001641172-25-010330.md) | 3.01 Delisting notice | 0001641172-25-010330 |
| 2025-04-30 | 16:15 ET | [DEF 14A](/filings/0001641172-25-007772.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007772 |
| 2025-04-18 | 16:30 ET | [8-K](/filings/0001641172-25-005428.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-005428 |
| 2025-03-21 | 08:15 ET | [8-K](/filings/0001493152-25-011083.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011083 |
| 2025-03-20 | 17:18 ET | [10-K](/filings/0001493152-25-011052.md) | Annual report, period 2024-12-31 | 0001493152-25-011052 |
| 2025-01-17 | 09:24 ET | [S-1](/filings/0001493152-25-002844.md) | Registration statement | 0001493152-25-002844 |
| 2024-12-20 | 12:40 ET | [SCHEDULE 13D/A](/filings/0001213900-24-110979.md) | Ownership report, active investor, amended | 0001213900-24-110979 |
| 2024-11-27 | 09:26 ET | [8-K](/filings/0001493152-24-047928.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-047928 |
| 2024-11-22 | 09:14 ET | [8-K](/filings/0001493152-24-047306.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-047306 |
| 2024-11-14 | 18:00 ET | [10-Q](/filings/0001493152-24-045220.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045220 |

Page 1 of 4. [Older](/companies/bfri/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:13 ET. No prices; not investment advice.